Fingerprint
Dive into the research topics of 'Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically